Department of Medical Research, Ministry of Health, Myanmar, Burma.
Ann Trop Med Parasitol. 1991 Dec;85(6):645-50. doi: 10.1080/00034983.1991.11812620.
One hundred and eight male adults (mean age 33 +/- 1.7 years) presenting with watery diarrhoea of less than 48 hours duration at home prior to hospitalization and with clinically evident (grade II, severe) dehydration were admitted into a randomized double-blind clinical trial; 54 were treated with standard oral rehydration solution (ORS)--WHO formulation containing citrate--and 54 with an improved ORS formulation which contained, in addition to the standard formula, maltodextrin 20 g (instead of glucose), glycine 4 g and glycyl-glycine 4 g. Patients with clinical cholera were given tetracycline 500 mg q.i.d. Vibrio cholerae was detected in 85 patients. The clinical characteristics of patients in the two groups were comparable. The improved ORS did not reduce the volume of diarrhoeic stools in cholera; indeed, patients with cholera who were treated with improved ORS had larger diarrhoea stool volumes. However, those cholera patients given improved ORS showed significantly greater weight gains during the first six-hour period, at the end of the second day, and at discharge. On the other hand, non-cholera patients treated with improved ORS had significantly smaller diarrhoeic stool volumes during the six to 24-hour significantly smaller diarrhoeic stool volumes during the six to 24-hour period (i.e. during the commencement of maintenance rehydration therapy).
108名成年男性(平均年龄33±1.7岁)在住院前在家中出现持续时间少于48小时的水样腹泻且有明显临床症状(II级,重度)脱水,被纳入一项随机双盲临床试验;54名患者接受标准口服补液盐(ORS)——世界卫生组织含柠檬酸盐的配方——治疗,54名患者接受改良的ORS配方治疗,该配方除标准配方外,还含有20克麦芽糊精(而非葡萄糖)、4克甘氨酸和4克甘氨酰甘氨酸。临床诊断为霍乱的患者给予四环素500毫克,每日4次。85名患者检测出霍乱弧菌。两组患者的临床特征具有可比性。改良的ORS并未减少霍乱患者的腹泻粪便量;实际上,接受改良ORS治疗的霍乱患者腹泻粪便量更大。然而,那些接受改良ORS治疗的霍乱患者在最初6小时、第二天结束时及出院时体重增加显著更多。另一方面,接受改良ORS治疗的非霍乱患者在6至24小时期间(即维持补液治疗开始时)腹泻粪便量显著更小。